SCHEMBL7429598

SCHEMBL7429598

O=C(O)Cc1scc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 2/20 0.46
GLA P06280 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PTGDR2 Q9Y5Y4 4/20 0.42
POLB P06746 1/20 0.42
AKR1B1 P15121 3/20 0.42
CYP1A2 P05177 1/20 0.41
RPS6KB2 Q9UBS0 1/20 0.41
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ADAMTS5 Q9UNA0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395762 0.84 MAPT (0.38) TDP1KDM4EALDH1A1HPGDGAA
SCHEMBL9195483 0.80 CYP1A2 (0.51) TDP1KDM4EALDH1A1CYP1A2RPS6KB2
SCHEMBL5538538 0.79 CYP2A6 (0.34) TDP1KDM4EALDH1A1HPGDGAA
SCHEMBL5842368 0.76 CYP2A6 (0.45) TDP1KDM4EALDH1A1HPGDGAA
SCHEMBL5320285 0.75 SLC7A5 (0.50) KDM4EALDH1A1MEN1KMT2A
SCHEMBL9351582 0.75 SLC7A5 (0.50) KDM4EALDH1A1MEN1KMT2A
SCHEMBL7140207 0.75 GAA (0.38) TDP1KDM4EALDH1A1HPGDGAA
SCHEMBL22528248 0.74 AKR1B1 (0.50) TDP1KDM4EALDH1A1HPGDGAA
SCHEMBL5323213 0.73 KIF11 (0.42) TDP1POLBKMT2A
SCHEMBL2095050 0.72 ALDH1A1 (0.35) TDP1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5256661-A Dopamiaergic agents; reducing intraocular pressure WHITBY RESEARCH, INC. (US) 1993-10-26 US disclosed
US-5177112-A Glucoma, dopaminergic response WHITBY RESEARCH, INC. (US) 1993-01-05 US disclosed
EP-0254989-A2 Substituted 2-Aminotetralins Whitby Research Incorporated (US) 1988-02-03 EP disclosed
EP-0048954-B1 BETA-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-12-30 EP disclosed
US-4346076-A Bis-tetrazoylmethyl substituted cephalosporin antibiotics ELI LILLY AND COMPANY (US) 1982-08-24 US disclosed
EP-0048169-A2 Bis-tetrazoylmethyl substituted cephalosporin antibiotics, their preparation and pharmaceutical formulations containing them ELI LILLY AND COMPANY (US) 1982-03-24 EP disclosed
EP-0002210-A1 6- and 6,6- disubstituted-2-substituted-pen-2-em-3-carboxylic acids; processes for their preparation and pharmaceutical compositions containing such compounds MERCK & CO. INC. (US) 1979-06-13 EP disclosed